Insider Title Company Date Price Return Shares Value
Velan Capital Investment Management Lp Non-Executive Jasper Therapeutics, Inc. (JSPR) 2024-02-08 $12.95 47.9% 350,000 $4,532,500
Return Profit / (loss) Cost
Total 47.9% $2,170,000 $4,532,500